Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That’s what I was thinking. Not the normal retail stuff.
jngreene33, For a trade that size (25M shares to be completed at one price ($.0014), it would have to have been pre-arranged. My guess it was part of some negotiations.
Thanks docsetc, thanks for the details. I guess I need to make my ENZC DD/details upto date, I am very much out of touch I guess. Can you please point me to the link or document that says ENZC is getting into the hardware distributor business. Also about the ITV1 failing toxicology tests and the IPF Immune not working and details of Clone3 and Clone7 etc,
Thanks really appreciate it!!
And that is the reality. Chandra run away with the AI after being part of ENZC. Now we sell urinal tablets! Crooks
Please be aware, ENZC has NO biotech to speak of at this moment. Zhabilov's ITV-1 failed toxicology tests and has been tossed into the back freezer as a shelf decoration. IPF-Immune also does not work. Clone3 and Clone7, and all other monoclonal antibody research material is over parked at the new MABS-Tech under Cotropia's watchful eye. not part of ENZC currently.
So, there is no biotech at all, right now, at ENZC, just a shell and some stories about turning into a hardware distributor. That could change, and that's where the speculation sits.
GLTY
So, on the other hand, someone BOUGHT 25M shares?? Awesome!
ToTheMoon
Initials are most likely,.... HZ.
Yeah, but we still love ya! I wasn't even thinking of you when I posted, I was thinking about a couple of idiots I saw on Twitter going crazy over that old matter.
GLTU!
IMHO, These are great price to add ENZC shares at these lower sub-penny levels. ENZC still has huge biotech, which has not gone away, their 40 years of research and hard work, with CURE for AIDS/infectious diseases, research on MS, Gut Biome, cancer and much more, they are not going to throw away. So one day there will be a Bidding War among multiple large Biotechs to BUYOUT ENZC, and these ridiculous ENZC prices will no longer be the same ever. Having said that ENZC is not a gamble, but a huge gem to be buying at these ridiculous prices. It will take a lot of patience and time, so IMHO these are great prices to accumulate more shares. JMHO
Someone dumped 25M shares in a single sale.
It’s been RIP for a long time now. I guess it took some this long to come to terms with it. Everyone’s welcome over in the 2024 version of 2020 ENZC lol. Train might be close to leaving the station there…
I apologize for bringing up Zimbler. In my opinion the debt owed to him (as well as Harry and the loan of $35,000 from a former director) should have been dealt with a long time ago. When the share price was over $0.50 a share Charles should have dealt with this, and it would have taken less than a million shares to remove everything under "Note 6. Related Party Transactions" in the filings. I believe I was incorrect about it being an annual payout (Thanks Valuator). I still can't figure out what the theory is that is the reason why KOP brought up ENZC SUB in recent tweets. Enzolytics, Inc. being the owner of the subsidiary is responsible for the debt until they sell the subsidiary. If I was just bringing up Zimbler because of a past debt that would be petty. The ENZC SUB was also created to protect Enzolytics, Inc. from legal matters that occurred prior to the merger. To those that think Zimbler is a "NON ISSUE", you may want to look at the Merganthaler vs Zimbler court case. I don't remember seeing Steve S. or Robustomed mentioned, but there are many associated with the current Enzolytics, Inc. listed in this case. I have not followed that case closely and they (Steve and Robustomed) may be mentioned in the filings. I believe Steve S. was recently added to one of the cases against Enzolytics, Inc., but I can't remember which one (I don't think it was this case). As to whether James or Billy Ray or any of the others from the past are currently involved, I cannot say. If Harry has worked with them in the past, what would stop him from working with them now? Remember this is an OTC Pink company that is NON-SEC reporting and they really don't have an obligation to report who they are working with.
https://www.courtlistener.com/docket/67807413/parties/mergenthaler-v-zimbler/
Is it tough being a genius DO B GONE? LOL.
Yeah, but even this is a half-step on the AI side alone, and the AI side is quite suspect at this point. It was the intel platform they collaborated on and became able to map the HIV and SARS viruses, maybe more we don't know about. Khapley AI is considered a suspect platform, even by some tech experts using it, so only time will tell there. Chandra's entire AI suite of platforms is based upon that. That AI would only accelerate such mappings and new drug options for consideration, not create them.
With no data published on Clone3/7, many have a strong case to bash this one.
Let's hope we're right and not blind.
GLTA
Well you are doing quite the followup on many items, thanks for that. Thank you for your patience as we continue to work on our website. It will provide information about #AI Drug Discovery Platform, partners, and our progress. We are currently testing and optimizing it before the official launch. https://t.co/9JcIYgDG6l #AIDD #HIV #Malaria #SARS
--
I do believe at this point Chandra said ALOT in his most recent Posting . WE is a strong statement, not just Chandra. Also discussion where they are headed with Proprietary AI, Information, Platforms coming out . I am sure the Attorney DNA in CC , is making sure they have an IRON WALL and BUFFER around them from the "Fradulent Four" of Harry , Barry, Kelli A and Steve S in whatever form that comes out with. It is coming, will be interesting to see what "IT" is and define really who "WE" are in the posting from ADNEXUS (Chandra) below. Until then they will keep the Lid on what is coming, just Business Protocol.
--
Quote
"Thank you for your patience as we continue to work on our website. It will provide information about #AI Drug Discovery Platform, partners, and our progress. We are currently testing and optimizing it before the official launch. https://"
Link
True, can't believe Zimbler is even coming back up. I've asked Chandra to get published data out, even as a private group if he must. With nothing published as respected fact regarding successful use of Clone3 and Clone7, even if just in lab testing results, that would cement the position they can make it move forward. Without that, the risk is high and getting a significant and inked partnership is a pipe dream. Shareholders won't move much on this ticker anymore until some form of respectable published data hits the wires, and an EU patent award projection is made.
The other 2 items I asked him to make a PR on, could wait a bit, but those first two are crucial.
In prior PRs and social media announcements, and private talks, we've been assured Clone3 and Clone7 are working well, both passed toxicology tests with 100% efficacy of no danger factors. But no verification data, just one-sided stories at this point. They've had 5 years now in their 'modern era' of tweaking both CloneX products, so they have no excuse. More years of development prior to that. There are no more excuses for them on the CCC side to not get serious.
I've also offered them an angle of some serious clout and free publicity. It's gone widely ignored. That makes me question why (?) To provide what I'm offering them, I have to lay my personal and professional reputations on the line, and I won't do it unless they can give me some sort of professional verifications of what they promise. They are way past Chandra's redundant theory and potential futures prose. That's not an insult aimed at Chandra or anyone else, just a bare, raw fact they can't ignore.
I've got one other investigative maneuver I can try, no more in-person visits to abandoned labs at Texas A&M, but something more direct.
GLTA
Me too, and I'll deal with the red buzzer itching the back of my brain.
Thanks docsetc.. As the price drifts lower..which I believe it will. Not sure how much though. I am adding. It's worth a gamble to me.
Folks J. Zimbler is a NON ISSUE , why in the World do folks keep going on on his involvement in ENZC. Long Gone , has been in OTC Land for Two Decades on various tickers , well known collaborator with TOXIC OTC people from long ago. He is over at EMG*,
---
Lets concentrate on the FRADULENT FOUR of Harry , Barry, Kelli A and Steve S . They are nearing the end of their smoke screen it appears when one looks at the Trades dwindling, price falling and they can only squeeze a turnip so much .
--
Onward and Forward. Not to worried about the Three C's , they have a strategy and they did not disappear , they are doing SOMETHING. Harry burned them and it will not be forgotten .
I agree completely with all of that Dawg, but one major concern pecks in the back of my brain regularly, and it's a very reasonable conflict.
With no published data of successful testing, of any significant kind, there is no proof they actually have what they claim, and it has been many years now. Any reasonable published test results, even lab testing results, would validate that both Clone3 and Clone7 are working well and ready to move forward. THAT ALONE, could cement forward movement here. A projection on EU patent awards, would add sizzle to pps upswings, when the situation is live again.
We have to decide just how mindless management is on all sides, or that they possibly are a scam and we're all super-duped. I lean very much along your direction, my similar direction and that of others here, but I have to remain a realist. I offered them some clout to get things going, and I was politely ignored on that out-of-hand, very strange. The politics behind it are well in CCC's favor, if they've been truthful as we expect they have been. When they turn down great, free publicity and clout that can assist them in great ways to get not only into final trials but to market with emphasis, what does that tell you?
I'm not certain myself, maybe they don't understand what I offered to do, but I'm concerned they were not even interested, twice now.
If Dr. Chandra is reading this one, I do hope he calls to discuss it. All sorts of investors and friends of the company offering to help them, and they go silent. What I've offered, could be tactically scheduled to positively synch with their own internal efforts, and they need all the help they can get at this point.
GLTY!
Biggest joke on the OTC= DO B GONE soon please. LOL
Thank you 1hunglo.
I understand that..I believe....
1. Harry wants out and he wants his money now.
2. Chandra and the Cs are not happy at all with what has happened and IMO they have the best interest of the ENZC shareholders at heart.
3. The Cs and Chandra had to protect the IP and when it hit the fan they did exactly that.
OK, we're close except for this:
The name Zimbler does not bother me. He is just an easy example. If "ALL DEBT" from the predecessor was to be part of ENZC SUB as stated in the Enzolytics and BioClonetics business combination agreement, then this issue should not be reported in the current filings. It's funny that Zimbler does not show up in the Enzolytics filings prior to the merger of Enzolytics and BioClonetics (at least the debt part from what I remember seeing). It is only after the completion of the merger between Enzolytics and BioClonetics that I can easily search for (especially now that the typo in his last name was fixed) and find his name in the filings.
"He is mentioned in every quarterly and annual that ENZC has filed.
Page 44 of the latest quarterly report."
Maybe I should have used a different phrase other than "not mentioned" to indicate that IMO, ENZC doesn't reveal or recognize any ongoing affiliation between itself and Zimbler since at least 12/31/2020, and maybe not since 2018, other than carrying forward a listing...by name of the creditor...of a potential liability on its Balance Sheet. That liability to Zimbler hasn't increased in value or changed since 2018. Maybe there is a reason for that, but the disclosures don't say. Harry's has decreased in the past. (I'm guessing Harry got paid.) An old debt does not indicate to me that there is a continuing relationship or affiliation with Zimbler. If there is, they've hidden it pretty well. JMHO.
Why does that name (Zimbler) bother you?
Re Austin: She has been associated with Harry for a long time. Either Mutat or Timing revealed that some time ago, and I found that she was the outside accountant for IMMB as far back as 2016.
"I may have misspoken about him being paid annually, and you may be correct that this is a debt that is just growing in value."
It's not increasing in value since 2018 and the disclosures in the financials say the liability does not earn interest. There's too much volume in the earlier reports to justify my time to dig out why there were small increases in the balance of the debt in prior years, but it might be interesting if you know the answers.
"If this debt was accrued prior to the Enzolytics and BioClonetics merger shouldn't this be debt of the predecessor? Why is it listed as owed by the current company and not a responsibility of Robustomed?"
It's listed by ENZC (the "current company") because the financials are presented on a consolidated basis, which includes the subsidiaries. Yes, I agree it should be the responsibility of Robusto and it is reflected that way in the Consolidating Balance Sheet of 12/31/2020. See the link I provided in my earlier post. Look at the middle column on the Statement:
That of course works too, but from just a business standpoint, if CCC was to merge a new company with ENZC and honor all ENZC common shares 1:1, then they'd want the fullest value they could get before making the new company public.
It's a doable gamble, but if anything goes wrong, their own shares go so low it may be self-destructive. It's just an Alice in Wonderland nightmare trying to predict lesser minds running PINK:OTC companies. Charles Cotropia alone should have been able to stop this.
GLTY!
Dogone, is that why Chandra consistently lies so he can keep the pps low? That will do it every time. Your suggestion is ridiculous as usual. Now do something you know how to do & give us a cartoon & remain in the back of the room where you belong. You may now delete this truthful post. You as top mod is indeed a great joke from inception to the present.
"Zimbler has apparently not been associated with ENZC in years and not mentioned at all since the merger with BioClonetics in November 2020. I don't see any current payments to him. Where are you getting that?"
He is mentioned in every quarterly and annual that ENZC has filed.
Page 44 of the latest quarterly report.
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content
As to his to him not having association with ENZC for years, I have no evidence of that. Kelli Austin appeared to have no affiliation with Harry or Enzolytics prior to the promissory convertible note issued 11/1/22 or the SAGA deal announced in 2023. Upon taking a deeper look there is a history between Kelli and Harry that goes back nearly a decade. I have not seen mention of Billy Ray in the filings but did find that he is linked to Enzolytics.
"Looking back at the notes to the financials, it looks like the balance due to him grew over several years in varying amounts, such as 14-20K per year to the final and current balance of $142,646 by the end of 2018 with an increase of only $1.1K since 2017. The company was doing business as ECO-PETROLEUM SOLUTIONS, INC. during most of that time, filing as Enzolytics, Inc. for the first time in 2018."
I may have misspoken about him being paid annually, and you may be correct that this is a debt that is just growing in value. I can't tell for sure because there really wasn't any transparency with their filings. If this debt was accrued prior to the Enzolytics and BioClonetics merger shouldn't this be debt of the predecessor? Why is it listed as owed by the current company and not a responsibility of Robustomed?
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content
JMHO: Zimbler has apparently not been associated with ENZC in years and not mentioned at all since the merger with BioClonetics in November 2020. I don't see any current payments to him. Where are you getting that?
Looking back at the notes to the financials, it looks like the balance due to him grew over several years in varying amounts, such as 14-20K per year to the final and current balance of $142,646 by the end of 2018 with an increase of only $1.1K since 2017. The company was doing business as ECO-PETROLEUM SOLUTIONS, INC. during most of that time, filing as Enzolytics, Inc. for the first time in 2018.
I don't see the reason for the debt, but it is unsecured, non-interest bearing and there is no due date. Same with Harry's $200+K. After so many years with no obligation to pay and no interest due, it looks more like "paid-in Capital" to me.
https://www.otcmarkets.com/otcapi/company/financial-report/262124/content
How about this. What if Chandra and the gang want the price to stay low so that Harry et al can go away with less and then make it easier to accumulate later..?
thanks doc .people think it cant happen in OTC but owcp is a example it can .Will look back for the information . They dont deserve to get away with what they did to honest investors.
Agree 100%. Chandra is DR. FOOLS GOLD imo. As stated in my last post.
Get your SEC complaint filed electronically now with the old link on this page. I don't have it handy at present, farting around online right now at an airport waiting on my flight.
Get that done first and use only Zhabilov's name for starters. If you complain about the CCC bunch who's no longer legally there, your complaint won't get but a second's look by anyone monitoring the growing list.
Then find anyone setting up the small class-action of defrauded shareholders. The risk of it not getting past an SEC warning stage to Zhabilov by the SEC, is for the reasons that: (1) it's in OTC:Pink land, so the priority will be low, (2) ENZC may have no assets left to act against as a company, (3) Zhabilov will run if investigated, dragging out a low priority case. If anyone unearths proof he sold off illegally as accused, and got millions out of it, some SEC official would pursue and prosecute. As they did with the old Pink stock "SpongeTech", and sent that guy up for a 10-year federal pen stint, after liquidating all of his personal assets in Florida.
The word “Chandra” literally means “bright”, “shining”, or “glittering”>>>
In the case of ENZC - - Chandra means FOOLS GOLD , as referenced above, for the simple fact he has never spoken the truth regarding this ticker to my knowledge & IMO.
Chandra is a crook. His claims were all lies. Only the blind don’t want to see it!
Yep! And who knows, (?) ENZC still has to prove itself after all of these years.
Never called ENZC a scam. Just saying the OTC landscape on a whole are TRADES not INVESTMENT type. People allow their emotions to get the best of them and don't apply strategies to minimize losses.
Well, with what you've written just below, your assumption already fell apart. He would not be able to fund any new venture with his IP's, because they're empty fakes as you've indicated.
If he is getting funding in any way, then you're wrong, CCC really does have something. Trading G's and Glows, always wanting it both ways.
GLTA
Can't argue that. Can only reiterate, no such scam has ever spent so much money on research and resources as ENZC obviously did. Scams run off with such money, they don't actually put it into real research.
ENZC did, pointing more likely to BAD MANAGEMENT, IMHO.
I've urged Chandra to come out with 3-4 critical PR's that would prove their worth, but he's sidestepped that for now. Not a good move at such a critical junction. If he or CCC as a whole, answered even 2 of those PR requests, that I may add are LONG OVERDUE, he'd prove their worth and position.
Right now, the Casino has gangsters with itchy trigger fingers at every exit.
GLTA
His first post he told the truth about ENZC, the next post he threw out the usual pumping fairytale la la land theory lol .. Dr. SCAMdra was in on it from the beginning.. now using the IP and our money to fund Adnexus... only a naive person would think it's a "hostile takeover by Harry" and CCC are going to "Take ENZC back" ... down 10% a day, will keep investors away!
What did the company owe Zimbler for? Was it a debt, severance package, or something else that was incurred during the time of the predecessor? If he is a former Director shouldn't his annual payments be coming from Robustomed? Aside from his annual payment, there is no mention of his role in the current Enzolytics (post Enzolytics and BioClonetics merger). If the CCC team do gain control of ENZC will Charles continue this annual payment to James?
Note 6. Related Party Transactions
As of March 31, 2024 and December 31, 2023, the Company owed to Directors, officers, and
stockholders of the Company $353,101 and $343,101, respectively. The amounts are unsecured,
noninterest bearing, and have no terms for repayment. The individual amounts owed to Directors, officers
and stockholders are presented as follows:
As of March 31, 2024 December 31, 2023
James W. Zimbler 142,646 142,646
Harry Zhabilov 200,455 200,455
Charles Cotropia 10,000
For a total of $353,101 $343,101
James W. Zimbler, a former Director and stockholder of the Company
Hopium is a powerful drug. Reality is a hard pill to swallow. The OTC is a Casino for the most part. Emotions need to be checked when taking risk. Stop talking about lawsuits and all that. Trade and TAKE PROFITS. Try not to get RECKED on the next TRADE. BOTTOMLINE.
Lawsuits are the ONLY answer these people are all scumbags!!!!!! If anyone has the information please start it now.
What makes you say this?
I'm quickly losing all faith in them. If they have ANYTHING in the works, they should put out a PR. Even if it's just that they have hired council. Even if it's just that they believe the previous board vote was fraudulent. They haven't even come out and said that officially. Only small hints, and very few of those have panned out on the last 3 years. This whole situation is sickening.
Hate to say it but it’s becoming obvious that the CCC scammed us!
Followers
|
1245
|
Posters
|
|
Posts (Today)
|
18
|
Posts (Total)
|
200067
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |